Coherus BioSciences Earning Date (CHRS)

USA |NASDAQ |USD

CHRS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 22, 2022 Dec 2021 $-0.44 $-0.49 $0.12
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 22, 2022 Dec 2021 $82.94M $82.50M $110.42M

Coherus Biosciences's next earnings date is Tuesday, Feb 22, 2022 for the fiscal quarter ending Dec 2021.

CHRS Earnings Date & History Chart

CHRS Earnings & Revenue Forecast

CHRS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 2 $-0.28 $-0.77 $0.20
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $-0.92 $-2.97 $0.79

CHRS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 0 / 0 $-0.28 $0.22 $0.22
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.92 $-0.31 $-0.43

CHRS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 3 $78.94M $75.00M $83.43M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 7 $343.97M $320.00M $384.39M

CHRS Earnings Date & Revenue History

CHRS Earnings History

|
Show More
Show More

CHRS Revenue History

|
Show More
Show More

Coherus Biosciences Next Earnings Date & Report

CHRS Next Earnings Date & Report Preview: Dec 2021 (FQ)

CHRS's next earnings date is Tuesday, Feb 22, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 4 analysts, the average EPS estimation for Coherus Biosciences's next quarterly earnings is $-0.44, with a low EPS estimation of $-0.77, and a high estimation of $-0.25.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.44, the last 2 month trend is $-0.24, and the 3 month trend is $-0.27.

Based on 6 analysts, the average revenue estimation is $82.94M, with a low revenue estimation of $78.82M, and a high estimation of $87.65M.

Coherus Biosciences Previous Earnings Dates & Reports

CHRS Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Coherus Biosciences's previous earnings date was Nov 8, 2021 for its fiscal quarter ended Sep 30, 2021.

CHRS's earnings per share (EPS) was $-0.49, missing the consensus analysts forecast of $-0.29 by -66.33%.

The EPS was lower than the previous fiscal quarter (Jun 2021) by 22.50%, and lower than the same period a year before (Sep 2020) by -248.48%.

Revenues were $82.50M, worse than the forecast of $91.31M by -9.65%, down by -5.86% from the previous quarter , and down by -27.34% from the same period last year.

The company reported a net income of $-38.53M.

Free cash flow for the quarter was $13.45M , compared to $-603.00K last quarter and $45.24M a year before.

CHRS ended the quarter with $418.77M in total debt, an increase of 0.20% compared to the previous quarter, and an increase of 1.21% compared to the same quarter a year before.

CHRS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Coherus Biosciences's previous annual earnings date was Feb 24, 2021 for its fiscal year ended Dec 31, 2020.

CHRS's earnings per share (EPS) was $1.63, missing the consensus analysts forecast of $1.72 by -5.23% , and higher than the previous year's EPS (Dec 2019) by 36.97%.

Revenues were $475.82M, worse than the forecast of $480.61M by -1.00%, and up by 33.63% from previous year's revenue.

The company reported a net income of $132.24M, 47.21% higher than the previous year.

Coherus Biosciences reported a free cash flow of $146.91M for its fiscal year, compared to $15.46M a year ago.

The company ended the fiscal year with $404.26M in total debt, an increase of 114.30% compared to the previous year.